<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00224926</url>
  </required_header>
  <id_info>
    <org_study_id>PPRU 10704</org_study_id>
    <nct_id>NCT00224926</nct_id>
  </id_info>
  <brief_title>The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation</brief_title>
  <official_title>The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Mercy Hospital Kansas City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore carrier and infection status of T.tonsurans tinea capitis and characterize the&#xD;
      host-pathogen interaction as it relates to the disease presentation. The general hypothesis&#xD;
      for this study is as follows: the type of genotypic and phenotypic variant to which a child&#xD;
      is exposed accounts for the presentation status observed in Trichophyton tonsurans&#xD;
      infection.The global outcome of this investigation is to reveal potential new drug targets&#xD;
      designed to improve treatment outcomes in these children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tinea capitis is an overwhelmingly prevalent disease of childhood estimated to be present in&#xD;
      approximately 1 in 20 children at any point in time with an equal number of children serving&#xD;
      as carriers of the fungal pathogen. Despite the widespread nature of the disease, the natural&#xD;
      course of the infection remains incompletely described. The study will be driven by the&#xD;
      following hypothesis: the type of genotypic and phenotypic variant to which a child is&#xD;
      exposed accounts for the presentation status observed in Trichophyton tonsurans infection.&#xD;
&#xD;
      A fungal scalp culture will be acquired from all participants using a brush culture&#xD;
      technique. Samples will be collected once a month over a two year time period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">September 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">446</enrollment>
  <condition>Tinea Capitis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scalp Brushing</intervention_name>
    <description>sterile, soft-head toothbrush massaged on scalp</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      fungal scalp cultures&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        preschool aged children&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preschool aged children will be eligible.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Rahman, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hosptials and Clinics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>September 21, 2005</study_first_submitted>
  <study_first_submitted_qc>September 21, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2005</study_first_posted>
  <last_update_submitted>September 16, 2011</last_update_submitted>
  <last_update_submitted_qc>September 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tinea Capitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinea Capitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

